SS INNOVATIONS INTERNAT.

SS Innovations reports preliminary unaudited revenues of about $15.0 million in Q4 2025, an increase of 85% year‑on‑year. The company installed 37 SSi‑Mantra systems in the quarter (+68%) and reached 103 installations for the year; the cumulative base rose to 168 systems (+158%). For 2025 SS Innovations expects around $43.0 million in revenue (+108% versus 2024). The company anticipates completion of the FDA‑510(k) review and CE marking in the first half of 2026 and plans to publish final figures before the end of February. » Plus sur de.investing.com

SS Innovations names Milan Rao effective immediately as global chief operating officer and chief financial officer; he succeeds Naveen Kumar Amar, who left for personal reasons. Rao brings more than 30 years of leadership experience in healthcare and other industries, as well as experience in M&A and capital allocation. The surgical robotics company, despite 158.36% revenue growth in the past twelve months, still reports losses (EBITDA -$8.39 million); the stock trades at $5.60 with a market capitalization of $1.12 billion and a price-to-book ratio of 27.35. » Plus sur de.investing.com

SS Innovations International made an interview with chairman and CEO Dr. Sudhir Srivastava, recorded on November 13, publicly available on NASDAQ’s "Live From MarketSite" platform. The company announced the release in a filing with the SEC and provided the information in accordance with Regulation FD; it is not a filing under the Securities Exchange Act of 1934. No additional financial or operational details were disclosed; the interview may contain forward-looking statements, and risks are described in prior SEC filings. » Plus sur de.investing.com